Maxray Optical Technology Co Ltd

(MXOP)

By |

Profile

Eidos Therapeutics Inc is a clinical stage biopharmaceutical company focused on addressing the large and growing unmet need in diseases caused by transthyretin, or TTR, amyloidosis, or ATTR. TTR is a protein that occurs naturally in the form of a tetramer and performs multiple beneficial roles, including the transport of essential hormones and vitamins.

Contact Information

Website: www.eidostx.com
Email: info@eidostx.com
Main Phone: +1 415 887-1471
Address: 101 Montgomery Street
Address 2: Suite 2000
State: CA
City / Town: San Francisco
Country: US
Postal Code: 94104

Issuer Information

Exchange: CVEM
CEO: Neil Kumar
Employees: 64
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Eidos Therapeutics Inc is a clinical stage biopharmaceutical company focused on addressing the large and growing unmet need in diseases caused by transthyretin, or TTR, amyloidosis, or ATTR. TTR is a protein that occurs naturally in the form of a tetramer and performs multiple beneficial roles, including the transport of essential hormones and vitamins.

Contact Information

Website: www.eidostx.com
Email: info@eidostx.com
Main Phone: +1 415 887-1471
Address: 101 Montgomery Street
Address 2: Suite 2000
State: CA
City / Town: San Francisco
Country: US
Postal Code: 94104

Issuer Information

Exchange: CVEM
CEO: Neil Kumar
Employees: 64
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 0.004 $ 0. (0.00%)
Last Price 0.004 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close 0.004
Last Trade Volume 0 52 Wk Hi 0.01 52 Wk Low 0.01
Market Cap 154,369 Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 38,592,203.00 EPS (TTM) -1.68 PE Ratio N/A Exchange CV EM